CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 4,550,357 shares at $17.06 ($77,606,339)
- 4 Grant or award Director acquired 2,317 shares (grant or award)
- 4 Exercise or conversion EVP, General Counsel acquired 7,467 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 33,714 shares (to pay taxes)
- 4 Exercise or conversion President, U.S. Businesses acquired 22,235 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 32,022 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 35,000,000 shares at $17.06 ($596,925,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP, Controller and CAO gave up 747 shares (to pay taxes)
- 4 Open-market sale U.S. President-Pharma Business sold 1,595 shares at $22.19 ($35,393)
- 4 Grant or award Director acquired 300 shares (grant or award)
- 4 Grant or award Director acquired 1,668 shares (grant or award)
- 4 Grant or award Director acquired 1,340 shares (grant or award)
- 4 Grant or award Director acquired 1,340 shares (grant or award)
- 4 Grant or award Director acquired 1,504 shares (grant or award)
- 4 Grant or award Director acquired 1,340 shares (grant or award)
Page 11 of 61 · 1,214 filings